Session Type
Meeting
Search Results for Outcomes
Oral Presentations
Abstract Number: 0007
SHM Converge 2025
Background: Glucagon-like peptide-1 (GLP-1) agonists are increasingly prescribed for obesity and type 2 diabetes, demonstrating efficacy in weight loss and glycemic control [1-3]. Beyond metabolic effects, these medications show protective effects against renal disease progression and reduce major adverse cardiovascular events [4]. GLP-1 agonists influence body composition through effects on both fat mass and fat-free [...]
Oral Presentations
Abstract Number: 0007
SHM Converge 2025
Background: Glucagon-like peptide-1 (GLP-1) agonists are increasingly prescribed for obesity and type 2 diabetes, demonstrating efficacy in weight loss and glycemic control [1-3]. Beyond metabolic effects, these medications show protective effects against renal disease progression and reduce major adverse cardiovascular events [4]. GLP-1 agonists influence body composition through effects on both fat mass and fat-free [...]
Abstract Number: 0060
SHM Converge 2025
Background: There is some observational evidence for the benefit of having an infectious diseases (ID) physician provide consultative support in the care of patients with Staphylococcus aureus bacteremia (SAB). A recent randomized trial was unable to document a similar benefit, although the control group received a concurrent stewardship intervention. We wanted to determine the effect [...]
Abstract Number: 0061
SHM Converge 2025
Background: UC Davis Medical Center is a 646-bed tertiary care center and level 1 pediatric and adult trauma center, serving over 33 counties. Most inpatient internal medicine consultations originate from orthopedic and trauma services, with a significant subset of fragility fractures and geriatric patients. We established a co-management service to provide additional assistance for the [...]
Abstract Number: 0108
SHM Converge 2025
Background: Inpatient hypoglycemia (HG) is common and often avoidable, associated with poor outcomes and high costs, and its prevention reflects hospital performance. We investigated its risk factors and impact on mortality, hospital length of stay (LOS), charges, and readmissions. We defined HG as glucose ≤40 mg/dl (severe), >40 – ≤70 mg/dl (moderate), or euglycemia >70 [...]
Abstract Number: 0127
SHM Converge 2025
Background: Onodera’s prognostic nutritional index (PNI) is useful in predicting prognosis of various diseases. In hospitalized patients, malnutrition is an important factor that affects the quality of life and morbidity. Here, we aimed to evaluate whether PNI is related with clinical outcomes in patients who admitted to hospitalist ward. Methods: This study included 3,993 patients [...]
Abstract Number: 0153
SHM Converge 2025
Background: In 2019, the US Food & Drug Administration issued a warning regarding safety of gabapentin use in patients with respiratory conditions, including chronic obstructive pulmonary disease (COPD). Gabapentin is widely prescribed, often for off-label indications, however limited data exist regarding safety and outcomes among patients with COPD. Methods: We analyzed data from 29 US [...]
Abstract Number: 0161
SHM Converge 2025
Background: Timely post-discharge office visits reduce readmission risk, but the association between telemedicine follow-up visits and readmission in patients discharged from the medicine service remains unclear. The COVID-19 pandemic led to a significant increase in telemedicine utilization for post-discharge follow-up, prompting questions about its association with readmission. Thus, our primary objective was to assess the [...]
Abstract Number: 0178
SHM Converge 2025
Background: Adverse events (AEs) after discharge occur in 19–28% of hospitalized patients.(1) Understanding whether patient-reported and clinical factors from the electronic health record (EHR) can predict post-discharge AEs is increasingly important given the growing population of hospitalized adults with multiple chronic conditions (MCC) being discharged home. This AHRQ-funded study aimed to develop an interoperable prediction [...]
Abstract Number: 0231
SHM Converge 2025
Background: Pulmonary embolism (PE) is the third most common cause of death from cardiovascular disease despite significant improvements in diagnosis and management in recent years. PE patients are risk-stratified to guide treatment, and multidisciplinary PE response teams (PERTs) have been established to optimize patient care. This study aims to compare PE patient outcomes over a [...]